To achieve stem cell-based therapy for canine DM for clinical use, further studies are required to establish a more effective differentiation protocol that induces increased insulin secretion in vitro and to determine the number of transplanted cells that are sufficient to improve hyperglycemic states in vivo. Here, INS is linked to diabetes mellitus.